Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients.

Source:http://linkedlifedata.com/resource/pubmed/id/21189474

Download in:

View as

General Info

PMID
21189474